A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a Phase III, global, randomized, parallel‐group, double‐blind, multicentre studyto assess the efficacy and safety of AZD6234 compared with placebo in adults with Type 2Diabetes Mellitus (T2DM) and obesity or overweight. Eligible participants will berandomized to either receive AZD6234 or matching placebo respectively.
Epistemonikos ID: 9dbd61743bd0b1e64d9335cf7043aac48bda00e5
First added on: Aug 26, 2026